Rise AbovePsoriatic Arthritis

[VIDEO PLACEHOLDER]

Steer Yourpsoriasis symptoms in a Different Direction

Rise AbovePsoriatic Arthritis

Are psoriatic arthritis (PsA) symptoms keeping you down?

Researchers are exploring ways to manage PsA and help those affected reach new heights on their treatment journey. Learn more about the LATITUDE Psoriatic Arthritis Studies today.

See If You May Qualify

Did You Know?

An estimated 30 percent of the 125 million people worldwide with psoriasis will develop psoriatic arthritis (PsA).1 Since approved treatments may not work for everyone, researchers are seeking other options.
PsA is unpredictable. Symptoms may vary in terms of how often they occur, how quickly they appear, and their severity level. Although psoriasis and psoriatic arthritis are overlapping and may occur on a spectrum, there is little correlation between psoriasis severity and PsA severity.1
It’s never too late to seek options for managing PsA symptoms—PsA usually develops between the ages of 30 and 50 but can occur at any age.1
Early diagnosis and finding the right treatment are both essential for managing PsA symptoms. Many people with PsA experience delays in getting diagnosed or are initially misdiagnosed with another condition.2 This diagnosis journey is not uncommon—more than 50 percent of those with PsA have at least one related medical condition, with heart disease being the most common.3

Help elevate psoriatic arthritis research with the LATITUDE Psoriatic Arthritis Studies.

See If You May Qualify

1 https://www.psoriasis.org/about-psoriatic-arthritis

2 Ogdie A, Nowell WB, Applegate E, et al., BMC Rheumatol. 2020;4:2. doi:10.1186/s41927-019-0102-7

3 https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/metabolic-comorbidities-of-psoriatic-arthritis

Did You Know?

An estimated 30 percent of the 125 million people worldwide with psoriasis will develop psoriatic arthritis (PsA).1 Since approved treatments may not work for everyone, researchers are seeking different options.
PsA is unpredictable. Symptoms may vary in terms of how often they occur, how quickly they appear, and their severity level. Although psoriasis and psoriatic arthritis are related, there is little correlation between psoriasis severity and PsA severity.1
It’s never too late to seek options for managing PsA symptoms––PsA usually develops between the ages of 30 and 50 but can occur at any age.1
Many people with PsA experience delays in getting diagnosed or are initially misdiagnosed with another condition.2 Early diagnosis and finding the right treatment are both essential for managing PsA symptoms.
More than 50 percent of people with PsA have at least one related medical condition, with heart disease being the most common.3 Researchers are looking for ways to help reduce this risk.

Help elevate psoriatic arthritis research with the LATITUDE Psoriatic Arthritis Studies.

See If You May Qualify

1 https://www.psoriasis.org/about-psoriatic-arthritis

2 Ogdie A, Nowell WB, Applegate E, et al., BMC Rheumatol. 2020;4:2. doi:10.1186/s41927-019-0102-7

3 https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/metabolic-comorbidities-of-psoriatic-arthritis

You may be able to participate in the LATITUDE Psoriatic Arthritis Studies if you:

Are 18 years of age or older
Have had signs and symptoms of psoriatic arthritis for at least 3 months
Have active
arthritis with:
- At least 3 tender joints
- At least 3 swollen joints
Have active psoriasis or nail changes from psoriasis

If you are interested in participating, the study doctor or staff will review additional study criteria with you.

Qualified participants will receive all study-related treatments and study-related care at no cost. Participants may be reimbursed for travel and expenses.
See If You May Qualify

What if you could potentially impact the 125 million people worldwide (2–3% of the entire population) with psoriasis?1 Embrace the future of psoriasis care with the LATITUDE Psoriasis Studies.

1 https://www.psoriasis.org/psoriasis-statistics/

About the LATITUDE Psoriatic Arthritis Studies

Embrace the future of psoriatic arthritis care with the LATITUDE Psoriatic Arthritis Studies. This program is evaluating an investigational oral treatment for adults with psoriatic arthritis.

The investigational treatment aims to control inflammatory signals known to contribute to the symptoms of psoriatic arthritis. Participants will receive the investigational treatment, an approved treatment (depending on the study you are in), or a placebo (a substance that looks like the investigational treatment but does not contain any active ingredients) while completing various study tests and procedures. 

Participants originally assigned to the placebo group will have the opportunity to switch to the investigational treatment during the study. All study treatments will be given as oral medications. 

Neither participants nor the study staff will know if participants are receiving the investigational treatment, approved oral treatment, or placebo. Participants should plan to attend up to 14 scheduled study visits over the course of up to 60 weeks. 
Home About the LATITUDE Psoriatic Arthritis Studies
See If You May Qualify
833-456-8226
Privacy Notice Terms and Conditions Cookie Policy Accessibility Statement
© 2025 Clinical Trial Media. All Rights Reserved. The images depicted contain models and are being used for illustrative purposes only.

Get Started

Enter your information below to begin.
Powered by
StudyKIK

By signing up you agree to receive text messages and emails about this study. You can unsubscribe at any time. Text messages and data rates may apply. You also agree that StudyKIK may provide your personal information to the research site to help determine if you qualify for this study. Please refer to StudyKIK's Privacy Policy and Terms of Service for more information.

Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences. 

For more detailed information on the cookies we use, please check our Privacy Policy. 

By continuing to access this website, you are giving us consent to collect cookies.

Accept